A detailed history of Geode Capital Management, LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,030,443 shares of CRBU stock, worth $3.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,030,443
Previous 1,905,661 6.55%
Holding current value
$3.98 Million
Previous $3.13 Million 26.69%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.56 - $2.73 $194,659 - $340,654
124,782 Added 6.55%
2,030,443 $3.96 Million
Q2 2024

Aug 09, 2024

BUY
$1.62 - $5.05 $102,834 - $320,563
63,478 Added 3.45%
1,905,661 $3.13 Million
Q1 2024

May 13, 2024

BUY
$4.82 - $8.26 $229,118 - $392,639
47,535 Added 2.65%
1,842,183 $9.47 Million
Q4 2023

Feb 13, 2024

BUY
$3.58 - $6.25 $778,675 - $1.36 Million
217,507 Added 13.79%
1,794,648 $10.3 Million
Q3 2023

Nov 13, 2023

BUY
$4.08 - $8.14 $1.9 Million - $3.79 Million
465,590 Added 41.89%
1,577,141 $7.54 Million
Q2 2023

Aug 11, 2023

BUY
$4.04 - $5.47 $169,385 - $229,340
41,927 Added 3.92%
1,111,551 $4.72 Million
Q1 2023

May 15, 2023

BUY
$4.3 - $7.78 $166,139 - $300,595
38,637 Added 3.75%
1,069,624 $5.68 Million
Q4 2022

Feb 13, 2023

BUY
$5.57 - $11.01 $254,086 - $502,243
45,617 Added 4.63%
1,030,987 $6.47 Million
Q3 2022

Nov 14, 2022

BUY
$5.34 - $12.79 $1.66 Million - $3.97 Million
310,597 Added 46.03%
985,370 $10.4 Million
Q2 2022

Aug 12, 2022

BUY
$5.1 - $9.74 $132,681 - $253,395
26,016 Added 4.01%
674,773 $3.66 Million
Q1 2022

May 13, 2022

BUY
$8.42 - $15.32 $2.42 Million - $4.4 Million
287,125 Added 79.4%
648,757 $5.96 Million
Q4 2021

Feb 11, 2022

BUY
$14.59 - $23.26 $283,294 - $451,639
19,417 Added 5.67%
361,632 $5.46 Million
Q3 2021

Nov 12, 2021

BUY
$15.75 - $30.29 $5.39 Million - $10.4 Million
342,215 New
342,215 $8.17 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $119M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.